• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Implications of COVID-19 for patients with pre-existing digestive diseases: an update.2019冠状病毒病对已有消化系统疾病患者的影响：最新进展
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):258-260. doi: 10.1016/S2468-1253(21)00025-X. Epub 2021 Feb 2.
2
Implications of COVID-19 for patients with pre-existing digestive diseases.2019冠状病毒病对患有既往消化系统疾病患者的影响。
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. doi: 10.1016/S2468-1253(20)30076-5. Epub 2020 Mar 11.
3
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.COVID-19 与消化系统：SARS-CoV-2 大流行期间的保护和管理。
Rev Esp Enferm Dig. 2020 May;112(5):389-396. doi: 10.17235/reed.2020.7128/2020.
4
Risk for Subsequent SARS-CoV-2 Infection and Severe COVID-19 Among Community-Dwellers With Pre-Existing Cervicocephalic Atherosclerosis: A Population-Based Study.人群中患有头颈部动脉粥样硬化的社区居民中再次感染 SARS-CoV-2 及发生严重 COVID-19 的风险：一项基于人群的研究。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319211070685. doi: 10.1177/21501319211070685.
5
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.新冠病毒大流行前对普通感冒人类冠状病毒的免疫会引起针对 SARS-CoV-2 抗原的回忆型 IgG 反应，但无交叉中和作用。
Front Immunol. 2022 Feb 11;13:790334. doi: 10.3389/fimmu.2022.790334. eCollection 2022.
6
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.与季节性冠状病毒预先存在的免疫有关的 SARS-CoV-2 易感性增加和 COVID-19 严重程度的证据。
Cell Rep. 2021 Dec 28;37(13):110169. doi: 10.1016/j.celrep.2021.110169. Epub 2021 Dec 7.
7
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
8
Potential relationships between COVID-19 and the thyroid gland: an update.COVID-19 与甲状腺之间潜在的关系：最新进展。
J Int Med Res. 2022 Feb;50(2):3000605221082898. doi: 10.1177/03000605221082898.
9
Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.越南儿童和成人的大流行前血浆中不存在 SARS-CoV-2 抗体。
Int J Infect Dis. 2021 Oct;111:127-129. doi: 10.1016/j.ijid.2021.07.072. Epub 2021 Jul 31.
10
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行：胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.

引用本文的文献

1
Spectrum of COVID-19 induced liver injury: A review report.新型冠状病毒肺炎所致肝损伤的研究现状：一篇综述报告
World J Hepatol. 2024 Apr 27;16(4):517-536. doi: 10.4254/wjh.v16.i4.517.
2
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?2023 年关于 COVID-19、可能的肝脏途径和酒精滥用，我们了解多少？
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
3
Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions.2019冠状病毒病期间及后2019冠状病毒病时代的胃肠病学与肝病：当前实践与未来方向
World J Clin Cases. 2021 Jul 6;9(19):4918-4938. doi: 10.12998/wjcc.v9.i19.4918.
4
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.**新冠疫情在消化科领域的现状：我们现在了解多少？** **新冠疫情对消化科影响的现有证据**。
United European Gastroenterol J. 2021 Sep;9(7):750-765. doi: 10.1002/ueg2.12115. Epub 2021 Jun 30.
5
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy.非肠道选择性生物制剂治疗的炎症性肠病患者 COVID-19 发病率较低。
J Gastroenterol Hepatol. 2021 Nov;36(11):3050-3055. doi: 10.1111/jgh.15591. Epub 2021 Jul 5.

本文引用的文献

1
Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study.新型冠状病毒2感染对实体器官移植受者的发病率及转归：一项基于全国人群的研究。
Am J Transplant. 2021 Jul;21(7):2509-2521. doi: 10.1111/ajt.16428. Epub 2021 Jan 20.
2
Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality.美国退伍军人中的肝硬化与严重急性呼吸综合征冠状病毒 2 感染：感染、住院、通气和死亡风险。
Hepatology. 2021 Jul;74(1):322-335. doi: 10.1002/hep.31649. Epub 2021 Jun 2.
3
Effect of IBD medications on COVID-19 outcomes: results from an international registry.IBD 药物对 COVID-19 结局的影响：来自国际注册研究的结果。
Gut. 2021 Apr;70(4):725-732. doi: 10.1136/gutjnl-2020-322539. Epub 2020 Oct 20.
4
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.炎症性肠病患者 COVID-19 的临床结局：一项全国性队列研究。
J Crohns Colitis. 2021 Apr 6;15(4):529-539. doi: 10.1093/ecco-jcc/jjaa215.
5
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.慢性肝病患者感染 SARS-CoV-2 后的结局：一项国际注册研究。
J Hepatol. 2021 Mar;74(3):567-577. doi: 10.1016/j.jhep.2020.09.024. Epub 2020 Oct 6.
6
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study.代谢综合征和非酒精性脂肪性肝炎患者中新冠病毒病的发病率：一项基于人群的研究。
Metabol Open. 2020 Dec;8:100057. doi: 10.1016/j.metop.2020.100057. Epub 2020 Sep 9.
7
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
8
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.2019冠状病毒病对肝病患者护理的影响：大流行6个月后的欧洲肝脏研究学会-欧洲临床微生物学与传染病学会立场文件
JHEP Rep. 2020 Oct;2(5):100169. doi: 10.1016/j.jhepr.2020.100169. Epub 2020 Aug 4.
9
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.《COVID-19 大流行期间肝功能异常患者的管理：亚太立场声明》。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-787. doi: 10.1016/S2468-1253(20)30190-4. Epub 2020 Jun 23.
10
Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience.慢性肝脏疾病对 COVID-19 住院患者结局的影响：美国多中心经验。
Liver Int. 2020 Oct;40(10):2515-2521. doi: 10.1111/liv.14583. Epub 2020 Jul 5.

Implications of COVID-19 for patients with pre-existing digestive diseases: an update.

作者信息

Mao Ren, Rieder Florian, Ben-Horin Shomron, Kaplan Gilaad G, Ng Siew C, Wong Grace Lh, Ghosh Subrata, Chen Min-Hu

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

出版信息

Lancet Gastroenterol Hepatol. 2021 Apr;6(4):258-260. doi: 10.1016/S2468-1253(21)00025-X. Epub 2021 Feb 2.

DOI:10.1016/S2468-1253(21)00025-X
PMID:33539813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7952087/
Abstract
摘要